CAI Caris Life Sciences, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$28.30
· of 52w range
· above low
· to high
$14.1952w low
$33.6652w high
Market Cap (MRQ)
$8.00B
P/E (TTM)
16.7
EPS (TTM)
$1.69
Revenue (TTM)
$990M
your badges
52W Range
$14–$34
Analyst Rating
STRONG BUY
Price Target
$28
P/E
16.7
ROE
20.1%
Net Profit Margin
10.6%
Your badge strip is empty — pin a metric anywhere on this page.
CAI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$28.30
Market Cap (MRQ)
$8.00B
P/E (TTM)
16.7
EPS (TTM)
$1.69
Revenue (TTM)
$990M
ROE (TTM)
20.1%
Debt/Equity (MRQ)
0.7
52W Range
$14–$34
CAI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$812M2023-12-31 → 2025-12-31
EPS$-3.222023-12-31 → 2025-12-31
Free Cash Flow$67M2025-12-31 → 2025-12-31
Net margin10.6%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 16.7 | · | · | · | |
| P/S (TTM) | 8.1 | · | 28.1 | Undervalued | |
| P/B (MRQ) | 13.5 | · | 9.0 | Fair value | |
| EV / EBITDA | 111.9 | · | · | · | |
| Price / FCF (TTM) | 64.5 | · | · | · | |
| Price / Cash Flow (TTM) | 47.4 | · | · | · | |
| EV / Revenue | 9.3 | · | · | · | |
| EV / FCF | 113.3 | · | · | · | |
| Price / Tangible Book | 14.3 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 15.5% | · | -116.3% | Top tier | |
| EBITDA Margin (TTM) | 17.6% | · | -116.3% | Top tier | |
| Pretax Margin (TTM) | 10.6% | · | -42.3% | Top tier | |
| Net Profit Margin (TTM) | 10.6% | · | -94.2% | Top tier | |
| ROA (TTM) | 9.6% | · | -20.7% | Top tier | |
| ROE (TTM) | 20.1% | · | -16.8% | Top tier | |
| ROIC | 4.7% | · | -6.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.7 | · | 0.7 | In line | |
| Current Ratio (MRQ) | 5.5 | · | 6.3 | Low liquidity | |
| Quick Ratio | 7.2 | · | 4.5 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.7 | · | 0.9 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 97.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CAI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.1 | · | 0.2 | Top tier | |
| Receivables Turnover | 8.1 | · | 5.7 | Top tier | |
| Revenue / Employee | ≈$439.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-585.8%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $0.00 | $0.01 | -100.0% |
| March 31, 2026 | $0.00 | $-0.02 | 100.0% | |
| Dec. 31, 2025 | $0.28 | $0.03 | 777.7% | |
| Sept. 30, 2025 | $0.08 | $-0.21 | 138.7% | |
| June 30, 2025 | $-7.97 | $-0.20 | -3845.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $812M | $412M | $306M | |
| R&D Expense | $102M | $114M | $117M | |
| SG&A Expense | $225M | $169M | $149M | |
| Operating Expenses | $767M | $669M | $626M | |
| Operating Income | $45M | $-257M | $-320M | |
| Other Non-op | $-21M | $-349.0K | $-13M | |
| Pretax Income | $-68M | $-282M | $-341M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-68M | $-282M | $-341M | |
| EPS (Basic) | $-3.22 | $-10.66 | $-13.24 | |
| EPS (Diluted) | $-3.22 | $-10.66 | $-13.24 | |
| Shares (Basic) | 167,205,616 | 35,496,832 | 34,942,691 | |
| Shares (Diluted) | 167,205,616 | 35,496,832 | 34,942,691 | |
| EBITDA | $68M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $796M | $64M | · | |
| Short-term Investments | $2M | $2M | · | |
| Receivables | $112M | $88M | · | |
| Prepaid Expense | $22M | $20M | · | |
| Other Current Assets | $2M | $7M | · | |
| Current Assets | $998M | $216M | · | |
| PP&E (Net) | $63M | $68M | · | |
| PP&E (Gross) | $304M | $296M | · | |
| Accum. Depreciation | $241M | $229M | · | |
| Goodwill | $19M | $19M | · | |
| Other Non-current Assets | $45M | $41M | · | |
| Total Assets | $1.13B | $344M | · | |
| Accounts Payable | $39M | $28M | · | |
| Accrued Liabilities | $88M | $78M | · | |
| Current Liabilities | $127M | $165M | · | |
| Capital Leases | $42M | $39M | · | |
| Other Non-current Liabilities | $42M | $44M | · | |
| Total Liabilities | $548M | $621M | · | |
| Long-term Debt | $378M | $373M | · | |
| Total Debt | $379M | · | · | |
| Common Stock | $283.0K | $38.0K | · | |
| Paid-in Capital | $3.14B | $0 | · | |
| Retained Earnings | $-2.55B | $-2.47B | · | |
| Treasury Stock | $17M | $330.0K | · | |
| AOCI | $936.0K | $210.0K | · | |
| Stockholders' Equity | $577M | $-2.50B | $-2.14B | |
| Liabilities + Equity | $1.13B | $344M | · | |
| Shares Outstanding | 282,526,097 | 35,842,319 | 35,297,278 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $23M | $49M | $49M | |
| Stock-based Comp | $70M | $19M | $15M | |
| Other Non-cash | $59M | · | · | |
| Operating Cash Flow | $83M | $-245M | $-276M | |
| CapEx | $16M | $8M | $22M | |
| Investing Cash Flow | $-16M | $53M | $215M | |
| Stock Repurchased | $113.0K | $0 | $0 | |
| Net Stock Activity | $-113.0K | · | · | |
| Financing Cash Flow | $665M | $200M | $10M | |
| Net Change in Cash | $732M | $8M | $-51M | |
| Free Cash Flow | $67M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | 5.6% | · | · | |
| Net Margin | -8.4% | · | · | |
| Pretax Margin | -8.4% | · | · | |
| EBITDA Margin | 8.3% | · | · | |
| ROA | -9.3% | · | · | |
| ROE | -13.2% | · | · | |
| ROIC | 4.7% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.8 | · | · | |
| Quick Ratio | 7.2 | · | · | |
| Debt / Equity | 0.7 | · | · | |
| LT Debt / Equity | 0.7 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 1.1 | · | · | |
| Receivables Turnover | 8.1 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $2.04 | · | · | |
| Revenue / Share | $4.86 | · | · | |
| Cash Flow / Share | $0.50 | · | · | |
| Cash / Share | $2.82 | · | · | |
| EPS (TTM) | $-3.22 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 97.0% | 34.7% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $812M | · | · | |
| Net Income TTM | $-68M | · | · | |
| Market Cap | $7.62B | · | · | |
| Enterprise Value | $7.20B | · | · | |
| P/E | -8.4 | · | · | |
| P/S | 9.4 | · | · | |
| P/B | 13.2 | · | · | |
| P / Tangible Book | 13.7 | · | · | |
| P / Cash Flow | 91.7 | · | · | |
| P / FCF | 113.9 | · | · | |
| EV / EBITDA | 106.4 | · | · | |
| EV / FCF | 107.7 | · | · | |
| EV / Revenue | 8.9 | · | · | |
| Earnings Yield | -11.9% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $216M | $293M | $217M | $181M | $121M | $130M | $102M | $100M | |
| R&D Expense | $32M | $31M | $32M | $22M | $25M | $23M | $27M | $28M | $25M | |
| SG&A Expense | $67M | $60M | $57M | $52M | $64M | $52M | $43M | $41M | $41M | |
| Operating Expenses | $237M | $211M | $204M | $184M | $199M | $179M | $167M | $162M | $167M | |
| Operating Income | $27M | $5M | $88M | $33M | $-18M | $-58M | $-37M | $-61M | $-67M | |
| Other Non-op | $-25M | $49.0K | $-2M | $-89.0K | $-18M | $-17.0K | $-26.0K | $37.0K | $-141.0K | |
| Pretax Income | $-614.0K | $-644.0K | $82M | $24M | $-72M | $-103M | $-37M | $-68M | $-66M | |
| Income Tax | $23.0K | $-134.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-637.0K | $-510.0K | $82M | $24M | $-72M | $-103M | $-37M | $-68M | $-66M | |
| EPS (Basic) | $0.00 | $0.00 | $1.61 | $0.09 | $-7.97 | $-3.57 | $-1.74 | $-2.59 | $-2.54 | |
| EPS (Diluted) | $0.00 | $0.00 | $1.61 | $0.08 | $-7.97 | $-3.57 | $-1.74 | $-2.59 | $-2.54 | |
| Shares (Basic) | 282,888,610 | 282,562,013 | · | 282,099,073 | 64,918,988 | 35,623,042 | · | 35,643,589 | 35,371,424 | |
| Shares (Diluted) | 282,888,610 | 282,562,013 | · | 297,211,838 | 64,918,988 | 35,623,042 | · | 35,643,589 | 35,371,424 | |
| EBITDA | $33M | $10M | · | $38M | $-12M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $820M | $796M | $753M | $719M | · | $64M | · | · | |
| Short-term Investments | $102M | $2M | $2M | $2M | $2M | · | $2M | · | · | |
| Receivables | $117M | $91M | $112M | $27M | $51M | · | $88M | · | · | |
| Prepaid Expense | $24M | $24M | $22M | $21M | $19M | · | $20M | · | · | |
| Other Current Assets | $5M | $4M | $2M | $3M | $3M | · | $7M | · | · | |
| Current Assets | $1.06B | $1.01B | $998M | $854M | $833M | · | $216M | · | · | |
| PP&E (Net) | $96M | $83M | $63M | $64M | $61M | · | $68M | · | · | |
| PP&E (Gross) | $347M | $328M | $304M | $304M | $303M | · | $296M | · | · | |
| Accum. Depreciation | $251M | $246M | $241M | $240M | $242M | · | $229M | · | · | |
| Goodwill | $19M | $19M | $19M | $19M | $19M | · | $19M | · | · | |
| Other Non-current Assets | $57M | $46M | $45M | $47M | $41M | · | $41M | · | · | |
| Total Assets | $1.23B | $1.16B | $1.13B | $985M | $955M | · | $344M | · | · | |
| Accounts Payable | $86M | $70M | $39M | $29M | $29M | · | $28M | · | · | |
| Accrued Liabilities | $105M | $74M | $88M | $57M | $61M | · | $78M | · | · | |
| Current Liabilities | $191M | $144M | $127M | $86M | $90M | · | $165M | · | · | |
| Capital Leases | $53M | $44M | $42M | $44M | $38M | · | $39M | · | · | |
| Other Non-current Liabilities | $53M | $44M | $42M | $44M | $38M | · | $44M | · | · | |
| Total Liabilities | $638M | $569M | $548M | $506M | $502M | · | $621M | · | · | |
| Long-term Debt | $393M | $381M | $378M | $376M | $373M | · | $373M | · | · | |
| Total Debt | $393M | $382M | · | $376M | $374M | · | · | · | · | |
| Common Stock | $283.0K | $284.0K | $283.0K | $283.0K | $282.0K | · | $38.0K | · | · | |
| Paid-in Capital | $3.14B | $3.16B | $3.14B | $3.12B | $3.12B | · | $0 | · | · | |
| Retained Earnings | $-2.55B | $-2.55B | $-2.55B | $-2.63B | $-2.66B | · | $-2.47B | · | · | |
| Treasury Stock | $0 | $17M | $17M | $17M | $17M | · | $330.0K | · | · | |
| AOCI | $529.0K | $893.0K | $936.0K | $748.0K | $669.0K | · | $210.0K | · | · | |
| Stockholders' Equity | $592M | $593M | $577M | $478M | $453M | · | $-2.50B | · | · | |
| Liabilities + Equity | $1.23B | $1.16B | $1.13B | $985M | $955M | · | $344M | · | · | |
| Shares Outstanding | 282,582,915 | 282,650,723 | 282,526,097 | 282,103,259 | 281,090,538 | · | 36,504,319 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $5M | $6M | $7M | $9M | $10M | $12M | |
| Stock-based Comp | $22M | $16M | $13M | $14M | $28M | $15M | $5M | $5M | · | |
| Other Non-cash | · | $12M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $28M | $33M | $45M | $62M | $7M | $-31M | $-39M | $-69M | · | |
| CapEx | $22M | $10M | $5M | $7M | $1M | $3M | $2M | $2M | · | |
| Investing Cash Flow | $-122M | $-10M | $-5M | $-7M | $-1M | $-3M | $-2M | $-2M | · | |
| Stock Repurchased | $21M | $0 | $91.0K | $0 | $0 | $22.0K | $0 | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-37M | $824.0K | $3M | $-21M | $681M | $1M | $226.0K | $87.0K | · | |
| Net Change in Cash | $-131M | $23M | $43M | $34M | $687M | $-33M | $-41M | $-71M | · | |
| Free Cash Flow | · | $23M | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.2% | 2.4% | · | 15.0% | -9.9% | · | · | · | · | |
| Net Margin | -0.24% | -0.24% | · | 11.2% | -39.6% | · | · | · | · | |
| Pretax Margin | -0.23% | -0.30% | · | 11.2% | -39.6% | · | · | · | · | |
| EBITDA Margin | 12.7% | 4.8% | · | 17.3% | -6.4% | · | · | · | · | |
| ROA | -0.06% | -0.09% | · | 4.9% | -15.0% | · | · | · | · | |
| ROE | -0.12% | -0.17% | · | 10.2% | -31.7% | · | · | · | · | |
| ROIC | 2.8% | 0.43% | · | 3.8% | -2.2% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 7.0 | · | 9.9 | 9.2 | · | · | · | · | |
| Quick Ratio | 1.1 | 6.3 | · | 9.1 | 8.6 | · | · | · | · | |
| Debt / Equity | 0.7 | 0.6 | · | 0.8 | 0.8 | · | · | · | · | |
| LT Debt / Equity | 0.7 | 0.6 | · | 0.8 | 0.8 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.4 | · | 0.4 | 0.4 | · | · | · | · | |
| Receivables Turnover | 3.1 | 4.8 | · | 16.2 | 7.1 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.09 | $2.10 | · | $1.70 | $1.61 | · | · | · | · | |
| Revenue / Share | $0.93 | $0.77 | · | $0.73 | $2.79 | · | · | · | · | |
| Cash Flow / Share | · | $0.12 | · | · | · | · | · | · | · | |
| Cash / Share | · | $2.90 | · | $2.67 | $2.56 | · | · | · | · | |
| EPS (TTM) | $1.69 | $-6.28 | · | $-13.20 | $-15.87 | $-10.44 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $990M | $907M | · | $649M | $534M | $452M | · | · | · | |
| Net Income TTM | $105M | $34M | · | $-187M | $-279M | $-273M | · | · | · | |
| Market Cap | $5.04B | $5.05B | · | $8.53B | $7.51B | · | · | · | · | |
| Enterprise Value | · | $4.61B | · | $8.15B | $7.16B | · | · | · | · | |
| P/E | 10.5 | -2.8 | · | -2.3 | -1.7 | · | · | · | · | |
| P/S | 5.1 | 5.6 | · | 13.1 | 14.1 | · | · | · | · | |
| P/B | 8.5 | 8.5 | · | 17.8 | 16.6 | · | · | · | · | |
| P / Tangible Book | 8.8 | 8.8 | · | 18.6 | 17.3 | · | · | · | · | |
| P / Cash Flow | · | 153.7 | · | · | · | · | · | · | · | |
| EV / Revenue | · | 5.1 | · | 12.6 | 13.4 | · | · | · | · | |
| Earnings Yield | 9.5% | -35.1% | · | -43.6% | -59.4% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $812M | $412M | $306M |
| Operating Margin % | 5.6% | · | · |
| Net Income | $-68M | $-282M | $-341M |
| Diluted EPS | $-3.22 | $-10.66 | $-13.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Debt / Equity | 0.7 | · | · |
| Current Ratio | 7.8 | · | · |
| Quick Ratio | 7.2 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $67M | · | · |
Institutional owners (13F) 259 filers · $2.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
259
Value held
$2.6B
New positions
67
Exited positions
23
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 67 (+9 vs prior Q) | 23 (-11 vs prior Q) | 110 (+19 vs prior Q) | 47 (+8 vs prior Q) | -665K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $551,063,502 | 30,923,878 | 20.97% | Shares |
| J. H. Whitney Equity Partners VI, LLC | $200,592,879 | 11,256,615 | 7.63% | Shares |
| COATUE MANAGEMENT LLC | $174,992,258 | 9,819,992 | 6.66% | Shares |
| BRAIDWELL LP | $147,122,490 | 8,256,032 | 5.60% | Shares |
| Sixth Street Partners Management Company, L.P. | $130,567,870 | 7,327,041 | 4.97% | Shares |
| PointState Capital LP | $121,689,840 | 6,828,835 | 4.63% | Shares |
| JPMORGAN CHASE & CO | $120,243,533 | 6,558,514 | 4.58% | Shares |
| BlackRock, Inc. | $98,665,739 | 5,536,798 | 3.76% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $86,327,760 | 4,844,431 | 3.29% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $76,273,841 | 4,280,238 | 2.90% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $70,541,023 | 3,958,531 | 2.68% | Shares |
| NEUBERGER BERMAN GROUP LLC | $63,990,963 | 3,590,963 | 2.44% | Shares |
| ORBIMED ADVISORS LLC | $50,017,372 | 2,806,811 | 1.90% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $42,238,176 | 2,370,268 | 1.61% | Shares |
| MILLENNIUM MANAGEMENT LLC | $39,251,170 | 2,202,647 | 1.49% | Shares |
| MAK CAPITAL ONE LLC | $34,521,421 | 1,937,229 | 1.31% | Shares |
| MORGAN STANLEY | $34,491,180 | 1,935,531 | 1.31% | Shares |
| Clearbridge Investments, LLC | $28,438,525 | 1,595,877 | 1.08% | Shares |
| FIL Ltd | $27,601,719 | 1,548,918 | 1.05% | Shares |
| UBS Group AG | $25,364,471 | 1,423,371 | 0.97% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $24,501,645 | 1,374,952 | 0.93% | Shares |
| STATE STREET CORP | $21,730,878 | 1,217,548 | 0.83% | Shares |
| Amundi | $21,711,246 | 1,218,364 | 0.83% | Shares |
| Capital World Investors | $21,620,507 | 1,213,272 | 0.82% | Shares |
| BANK OF AMERICA CORP /DE/ | $21,394,512 | 1,200,590 | 0.81% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $20,546,499 | 1,149,133 | 0.78% | Shares |
| Point72 (DIFC) Ltd | $19,807,458 | 654,792 | 0.75% | Shares |
| Champlain Investment Partners, LLC | $18,690,721 | 1,048,862 | 0.71% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $18,615,787 | 1,044,657 | 0.71% | Shares |
| GOLDMAN SACHS GROUP INC | $16,963,607 | 951,942 | 0.65% | Shares |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | $14,293,119 | 802,083 | 0.54% | Shares |
| SEI INVESTMENTS CO | $13,590,584 | 762,659 | 0.52% | Shares |
| Trexquant Investment LP | $12,971,962 | 727,944 | 0.49% | Shares |
| Woodline Partners LP | $12,886,765 | 723,163 | 0.49% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $11,683,576 | 655,644 | 0.44% | Shares |
| Nuveen, LLC | $10,770,693 | 604,416 | 0.41% | Shares |
| AMERIPRISE FINANCIAL INC | $10,207,012 | 572,784 | 0.39% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $10,121,760 | 568,000 | 0.39% | Shares |
| Rock Springs Capital Management LP | $8,687,250 | 487,500 | 0.33% | Shares |
| Quantinno Capital Management LP | $7,870,595 | 441,672 | 0.30% | Shares |
| Walleye Capital LLC | $7,562,933 | 424,407 | 0.29% | Shares |
| Squarepoint Ops LLC | $6,788,119 | 380,927 | 0.26% | Shares |
| TD Asset Management Inc | $6,760,694 | 379,388 | 0.26% | Shares |
| Bank of New York Mellon Corp | $5,495,813 | 308,407 | 0.21% | Shares |
| MENLO ADVISORS LLC | $5,355,000 | 300,518 | 0.20% | Shares |
| CITADEL ADVISORS LLC | $5,307,776 | 297,855 | 0.20% | Shares |
| FEDERATED HERMES, INC. | $5,089,356 | 285,598 | 0.19% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $4,705,622 | 264,064 | 0.18% | Shares |
| NORTHERN TRUST CORP | $4,611,584 | 258,787 | 0.18% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $4,412,000 | 247,605 | 0.17% | Shares |
Company insiders 15 insiders · 5 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David D Halbert | Founder, Chairman, and Chief Executive Officer | May 15, 2026 F | 2,574,533 | 0 | 0 | $0 |
| Luke Thomas Power | Senior Vice President, Chief Financial Officer, and Chief Accounting Officer | May 15, 2026 F | 153,771 | 0 | 2 | $-1,654,200 |
| David Baxley Spetzler | President | Sept. 4, 2026 M | 1,182,871 | 1 | 3 | $-14,824,973 |
| John Russel Denton | Senior Vice President, General Counsel, and Secretary | Sept. 22, 2026 S | 174,855 | 1 | 1 | $-137,857 |
| Brian J Brille | Vice Chairman and Executive Vice President | Sept. 17, 2026 M | 230,303 | 0 | 1 | $-12,132,000 |
| David Paul Fredrickson | Director | Aug. 14, 2026 A | 31,813 | 0 | 0 | $0 |
| Lloyd Minor | Director | Aug. 14, 2026 A | 31,813 | 0 | 0 | $0 |
| Jeff L Vacirca | Director | Aug. 14, 2026 A | 62,863 | 1 | 0 | $501,458 |
| Joseph E Gilliam | Director | Aug. 14, 2026 A | 29,321 | 0 | 0 | $0 |
| Jonathan Kenneth Charles Knowles | Director | May 29, 2026 A | 308,979 | 0 | 0 | $0 |
| George Poste | Director | May 29, 2026 A | 17,729 | 0 | 0 | $0 |
| Danny T Phillips | · | Aug. 14, 2026 A | 133,060 | 0 | 0 | $0 |
| Peter M Castleman | · | Aug. 14, 2026 A | 29,321 | 0 | 0 | $0 |
| Laura I Johansen | · | Aug. 14, 2026 A | 343,897 | 0 | 0 | $0 |
| Jon Halbert | · | Aug. 14, 2026 A | 131,813 | 1 | 0 | $990,080 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 52 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IDNA · iShares Trust | 2.86% | 304,470 SH | Sept. 11, 2026 | Daily |
| EWO · iShares, Inc. | 1.95% | 152,334 SH | Sept. 11, 2026 | Daily |
| GURU · Global X Funds | 1.13% | 44,189 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.54% | 19,982 SH | Oct. 2, 2026 | Daily |
| IBB · iShares Trust | 0.22% | 935,069 SH | Sept. 11, 2026 | Daily |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.14% | 51,508 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.11% | 31,445 SH | Oct. 2, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.11% | 106,273 NS | July 31, 2026 | N-PORT |
| IFGL · iShares Trust | 0.10% | 2,969 SH | Sept. 11, 2026 | Daily |
| VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.09% | 137,830 SH | Aug. 19, 2026 | Daily |
| ISCG · iShares Trust | 0.09% | 34,137 SH | Sept. 11, 2026 | Daily |
| IWP · iShares Trust | 0.08% | 622,793 SH | Sept. 11, 2026 | Daily |
| BKSE · BNY Mellon ETF Trust | 0.08% | 4,273 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 29,220 NS | July 31, 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.06% | 1,686,026 SH | Aug. 19, 2026 | Daily |
| TECB · iShares Trust | 0.06% | 12,038 SH | Sept. 11, 2026 | Daily |
| TEXN · iShares Trust | 0.05% | 383 SH | Sept. 11, 2026 | Daily |
| IYH · iShares Trust | 0.05% | 71,964 SH | Sept. 11, 2026 | Daily |
| IEUS · iShares Trust | 0.04% | 2,904 SH | Sept. 11, 2026 | Daily |
| ERET · iShares Trust | 0.04% | 221 SH | Sept. 10, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.04% | 15,463 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.04% | 65,388 SH | Sept. 11, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.03% | 4,393 SH | Oct. 2, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.03% | 2,916,159 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.03% | 6,910 SH | Sept. 11, 2026 | Daily |
| IWR · iShares Trust | 0.02% | 510,004 SH | Sept. 11, 2026 | Daily |
| SCZ · iShares Trust | 0.02% | 104,416 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 99,335 SH | Aug. 19, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 175,923 SH | Aug. 19, 2026 | Daily |
| IWF · iShares Trust | 0.01% | 407,269 SH | Sept. 11, 2026 | Daily |
| IEUR · iShares Trust | 0.01% | 25,697 SH | Sept. 9, 2026 | Daily |
| IEFA · iShares Trust | 0.00% | 348,728 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 6,004 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 35,576 SH | Sept. 10, 2026 | Daily |
| IWB · iShares Trust | 0.00% | 85,113 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 81,853 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.00% | 38,859 SH | Sept. 10, 2026 | Daily |
| IWS · iShares Trust | 0.00% | 18,838 SH | Sept. 10, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.00% | 9,530 NS | July 31, 2026 | N-PORT |
| IWD · iShares Trust | 0.00% | 28,096 SH | Sept. 11, 2026 | Daily |
| REVS · Columbia ETF Trust I | 0.00% | 102 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4,049,150 SH | Aug. 19, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 401,488 SH | Aug. 19, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 62,312 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 119,464 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 255,409 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,236 SH | Aug. 19, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,623 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,468 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 5,343 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.00% | 27,996 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 4,759 SH | Sept. 11, 2026 | Daily |
CAI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 16 analysts
BUY
Median target
$28.00
-1.1%
6 37.5%
Strong Buy
6 37.5%
Buy
4 25.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
13 analysts · 2026-09-30Mean target $28.15 -0.5%
Now
Current price $28.30
Low$22.00
Mean$28.15
High$36.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
Latest News Recent headlines mentioning this company
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
Yahoo Finance · 3 months ago
Caris Life Sciences Authorized Buy Back Up To $100 Mln
Nasdaq · 3 months, 3 weeks ago
Caris Life Sciences (CAI) Expands AI Insights Portfolio With Signature to Predict Ovarian Cancer Platinum Resistance
Yahoo Finance · 6 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026